Abstract
This chapter reviews the neuroimaging features of the potential effects of nasal decongestants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Carr WW, Nelson MR, Hadley JA. Managing rhinitis: strategies for improved patient outcomes. Allergy Asthma Proc. 2008;29(4):349–57.
Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy. 1997;52(40 Suppl):28–34.
Mortuaire G, de Gabory L, François M, Massé G, Bloch F, Brion N, Jankowski R, Serrano E. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(3):137–44.
Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148–55.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ginat, D.T. (2022). Nasal Decongestants. In: Ginat, D.T., Small, J.E., Schaefer, P.W. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-031-08774-5_47
Download citation
DOI: https://doi.org/10.1007/978-3-031-08774-5_47
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08773-8
Online ISBN: 978-3-031-08774-5
eBook Packages: MedicineMedicine (R0)